期刊文献+

地塞米松对人肝癌细胞系SMMC-7721细胞酪氨酸转氨酶活性诱导能力丧失的机制研究

Lost sensibility of tyrosine aminotransferase to dexamethasone in human hepatoma cell line SMMC-7721
下载PDF
导出
摘要 目的:通过测定人肝癌SMMC 7721细胞酪氨酸转氨酶(TAT)cDNA序列,并观察其糖皮质激素受体(GR)通路是否存在异常,以探讨地塞米松(Dex)丧失诱导SMMC-7721细胞TAT活性的机制。方法:RT-PCR扩增SMMC-7721细胞全长TAT cDNA并进行测序;采用实时定量PCR观察Dex对SMMC-7721细胞TAT mRNA表达的影响,并与HepG2细胞作对照;采用电穿孔法将GR特异性报告基因GRE-tk-LUC及GRE-MMTV CAT分别瞬时转入SMMC-7721细胞中,观察Dex对荧光素酶(LUC)和氯酶素乙酰转移酶(CAT)表达的影响,并与HepG2细胞作对照。结果:SMMC-7721细胞TAT cDNA中第576位碱基存在同义突变;Dex能够诱导SMMC-7721细胞中TAT mRNA的表达,最大诱导倍数为2.22,明显低于HepG2细胞(15.1倍,P<0.01);Dex诱导了SMMC-7721细胞LUC及CAT的表达,与HepG2细胞无显著差异。结论:Dex对SMMC-7721细胞TAT mRNA诱导水平降低,可能是TAT活性不增高的主要原因。 Objective:To investigate the mechanism responsible for lost sensibility of tyrosine aminotransferase (TAT) to dexamethasone(Dex) in human hepatoma cell line SMMC-7721 through examining the cDNA sequence of TAT and the status of glucocorticoid receptor (GR) pathway. Methods: The TAT cDNA fragment containing the full length of coding sequence was amplified by reverse transcription-polymerase chain reaction (RT-PCR) and was sequenced. The expression of TAT mRNA was determined by real-time quantitative PCR to observe the influence of Dex on expression of TAT mRNA in SMMC-7721 cells. The experiement with HepG2 cells was performed as the control. Reporter genes (GRE-tk-LUC and GRE-MMTV-CAT ) were transiently transfected into SMMC-7721 cells by electroporation. The induction efficiencies of LUC and CAT genes expression by Dex were examined and compared between SMMC-7721 cells and HepG2 cells. Results: The results showed that there was a same-sense mutation (Gln576Gln) in TAT cDNA sequence. TAT mRNA could be induced by Dex,with the maximal induction level being 2. 22-folds in SMMC-7721 cells,which was significantly lower than that in HepG2 cells (15.1-fold increase, P〈0.01 ). Dex induced the expression of LUC and CAT genes in SMMC- 7721 cells as well as the HepG2 cells. Conclusion: The induction efficiency of Dex for expression of TAT mRNA is decreased in SMMC- 7721 cells,which might be due to the unchanged activity of TAT.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2008年第6期630-633,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金重点项目(39730210).~~
关键词 糖皮质激素 受体 酪氨酸转氨酶 转录激活 glucocorticoids receptor tyrosine aminotransferase transcriptional activation
  • 相关文献

参考文献16

  • 1Einstein M, Greenlee M, Rouen G, Sitlani A, Santoro J, Wang C,et al. Selective glucocorticoid receptor nonsteroidal ligands completely antagonize the dexamethasone mediated induction of enzymes involved in gluconeogenesis and glutamine metabolism [J].J Steroid Biochem Mol Biol, 2004,92 z 345-356.
  • 2Chinenov Y, Rogatsky I. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network [J]. Mol Cell Endocrinol, 2007,275 (1-2) : 30-42.
  • 3Yoh T, Nakashima T,Sumida Y, Kakisaka Y, Nakajima Y, Ishikawa H,et al. Effects of glyeyrrhizin on glueocorticoid signaling pathway in hepatoeytes[J]. Dig Dis Sei,2002,47:1775-1781.
  • 4Sevaljevic L, Isenovic E, Vulovic M, Macvanin M, Zakula Z, Kanazir D, et al. The responses of rat liver glucocortieoid receptors and genes for tyrosine aminotransferase, alpha-2-macroglobulin and gamma-fibrinogen to adrenalectomy-,dexamethasone-and inflammation-induced changes in the levels of glucocorticoids and proinflammatory cytokines [J]. Biol Signals Recept, 2001,10 : 299-309.
  • 5Nimi S, Yamaguchi T, Hayakawa T. Effect of dexamethasone pretreatment on the dexamethasone-dependent induction of tyrosine aminotransferase activity in primary cultured rat hepatocytes[J]. Biol Pharm Bull, 1998,21 : 1009-1012.
  • 6Thompson E B, Aviv D, Lippman M E. Variants of HTC cells with low tyrosine aminotransferinase inducibility and apparently normal glucorticoid receptors [J]. Endocrinology, 1977,100: 406-419.
  • 7盛宗梅 陈惠黎.H615肝癌和HepA腹水肝癌的酶学比较Ⅱ.酪氨酸-α-酮戊二酸转氨酶的活力及诱导的变化[J].上海第一医学院学报,1983,10:283-283.
  • 8卢建 徐仁宝 等.人体肝癌细胞系(SMMC-7721)的糖皮质激素受体以及糖皮质激素对酪氨酸转氨酶的诱导[J].实验生物学报,1985,18(2):231-238.
  • 9李忆东,刘宇健,卢建.地塞米松对人肝癌细胞系酪氨酸转氨酶mRNA表达的影响[J].第二军医大学学报,2002,23(2):176-178. 被引量:1
  • 10叶华茂,孙颖浩,许传亮,王林辉,侯建国,高旭,杨庆,刘智勇.雄激素非依赖性前列腺癌细胞亚系模型LNCaP-AI的建立[J].第二军医大学学报,2008,29(1):59-62. 被引量:5

二级参考文献9

  • 1卢建 徐仁宝 等.人体肝癌细胞系(SMMC-7721)的糖皮质激素受体以及糖皮质激素对酪氨酸转氨酶的诱导[J].实验生物学报,1985,18(2):231-238.
  • 2Shi X B,Ma A H,Tepper C G,Xia L,Gregg J P,Gandour-Edwards R, et al. Molecular alterations associated with LNCaP cell progression to androgen independence[J]. Prostate, 2004, 60:257-271.
  • 3Akakura K, Bruchovsky N, Goldenberg S L, Rennie P S, Buckley A R, Sullivan L D. Effects of intermittent androgen suppression on androgen-dependent tumors: apoptosis and serum prostate-specific antigen[J]. Cancer, 1993,71:2782-2790.
  • 4Wu J P,Gu F L. The prostate 41-65 years post castration:an analysis of 26 eunuchs[J]. Chin Med J (Engl), 1987, 100: 271- 272.
  • 5Berchem G J, Bosseler M, Sugars L Y, Voeller H J, Zeitlin S, Gelmann E P. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells[J]. Cancer Res, 1995, 55:735-738.
  • 6Culig Z, Hoffmann J, Erdel M, Eder I E, Hobisch A, Hittmair A,et al. Switch from antagonist to agonist of the androgen receptor biealutamide is associated with prostate tumour progression in a new model system[J]. Br J Cancer, 1999,81:242-251.
  • 7Hara T, Miyazaki J, Araki H, Yamaoka M, Kanzaki N, Kusaka M, et al. Novel mutation of androgen receptor: A possible mechanism of bicalutamide withdrawal syndrome [J]. Cancer Res, 2003,63 : 149-153.
  • 8van Steenbrugge G J, van Uffelen C J, Bolt J, Schroder F H. The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity [J]. J Steroid Biochem Mol Biol,1991,40:207-214.
  • 9Yuan T C,Veeramani S, Lin F F, Kondrikou D,Zelivianski S, Igawa T, et al. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells[J]. Endocr Relat Cancer,2006,13:151-167.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部